Efficient transgene regulation from a single tetracycline-controlled positive feedback regulatory system

Gene Therapy

Volumn 5, Issue 1, 1998, Pages 76-84

  A Mohammadi, S ^a,c   Hawkins, R E ^a,b  

^a MRC Centre   (Germany)

^b BRISTOL HAEMATOLOGY AND ONCOLOGY CENTRE   (United Kingdom)

^c MEDICAL RESEARCH COUNCIL   (United Kingdom)

Author keywords

Bidirectional promoter; Gene therapy; mGM CSF; Positive feedback regulatory system; Tetracycline controlled transactivator; tTA responsive promoter

Indexed keywords

GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; TETRACYCLINE; TRANSACTIVATOR PROTEIN;

ARTICLE; CONTROLLED STUDY; DNA TRANSFECTION; EXPRESSION VECTOR; GENE EXPRESSION REGULATION; HELA CELL; HUMAN; HUMAN CELL; POSITIVE FEEDBACK; PRIORITY JOURNAL; PROMOTER REGION; TRANSGENE;

CUCUMBER MOSAIC VIRUS; EUKARYOTA;

EID: 0031962433     PISSN: 09697128     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.gt.3300557     Document Type: Article

References (51)

1. Schmidt W et al. Cancer vaccines: the interleukin 2 dosage effect. Proc Natl Acad Sci USA 1995; 92: 4711-1714.
2. Stevenson FK et al. Idiotypic DNA vaccines against B cell lymphoma. Immunol Rev 1995; 145: 211-228.
3. Brandt SJ et al. Effect of recombinant human granulocyte-macrophage colony-stimulating factor on hematopoietic reconstitution after high-dose chemotherapy and autologous bone marrow transplantation. New Engl J Med 1988; 318: 869-875.
4. Dranoft G et al. Vaccination with irradiated tumor cells engineered to secrete murine granulocyte-macrophage colony-stimulating factor stimulates potent, specific, and long-lasting antitumor immunity. Proc Natl Acad Sci USA 1993; 90: 3539-3543.
5. Schweinfest CW, Jorcyk CL, Fujiwara S, Papas TS. A heat shock-inducible eukaryotic expression vector. Gene 1988, 71: 207-210.
6. Labow MA, Baim SB, Shenk T, Levine AJ. Conversion of the lac repressor into an allosterically regulated transcriptional activator for mammalian cells. Mol Cell Biol 1990; 10: 3343-3356.
7. Israel DI, Kaufman RJ. Highly inducible expression from vectors containing multiple GREs in CHO cells overexpressing the glucocorticoid receptor. Nucleic Acids Res 1989; 17: 4589-4604.
8. Palmiter RD, Chen HY, Brinster RL. Differential regulation of metallothionein-thymidine kinase fusion genes in transgenic mice and their offspring. Cell 1982; 29: 701-710.
9. McGrane NM, Yun JS, Patel YM, Hanson RW. Metabolic control of gene expression: in vivo studies with transgenic mice. Trends Biochem Sci 1992; 17: 40-44.
10. Jones SN et al. Induction of the cypla-1 dioxin-responsive enhancer in transgenic mice. Nucleic Acids Res 1991; 19: 6547-6551.
11. Gossen M, Bujard H. Tight control of gene expression in mammalian cells by tetracycline-responsive promoters. Proc Natl Acad Sci USA 1992; 89: 5547-5551.
12. Degenkolb J, Takahashi M, Ellestad GA, Hillen W. Structural requirements of tetracycline-tet repressor interaction: determination of equilibrium binding constants for tetracycline analogs with the tet repressor. Antimicrob Agents Chemother 1991; 35: 1591-1595.
13. Furth PA et al. Temporal control of gene expression in transgenic mice by a tetracycline-responsive promoter. Proc Natl Acad Sci USA 1994; 91: 9302-9306.
14. Passman RS, Fishman GI. Regulated expression of foreign genes in vivo after germline transfer. J Clin Invest 1994; 94: 2421-2425.
15. Efrat S et al. Conditional transformation of a pancreatic β-cell line derived from transgenic mice expressing a tetracycline-regulated oncogene Proc Natl Acad Sci USA 1995; 92- 3576-3580.
16. Shockett PE, Schatz DG. Diverse strategies for tetracycline-regulated inducible gene expression. Proc Natl Acad Sci USA 1996; 93: 5173-5176.
17. Hillen W, Berens C. Mechanisms underlying expression of Tn10 encoded tetracycline resistance. Annu Rev Microbiol 1994; 48: 345-369.
18. O'Hare P. The virion transactivator of herpes simplex virus. Semin Virol 1993; 4. 145-155.
19. Fishman GI, Kaplan ML, Buttrick PM. Tetracycline-regulated cardiac gene expression in vivo. J Clin Invest 1994; 93: 1864-1868.
20. Dhawan J et al. Tetracycline-regulated gene expression following direct gene transfer into mouse skeletal muscle. Somatic Cell Mol Gen 1995; 21: 233-240.
21. Neering SJ et al. Transduction of primitive human hematopoietic cells with recombinant adenovirus vectors. Blood 1996; 88. 1147-1155.
22. Liang X et al. Novel, high expressing and antibiotic-controlled plasmid vectors designed for use in gene therapy. Gene Therapy 1996; 3. 350-356.
23. Schultze N et al. Efficient control of gene expression by single step integration of the tetracycline system in transgenic mice. Nature Biotechnol 1996; 14: 499-503.
24. Paulus W et al. Self-contained, tetracycline-regulated retroviral vector system for gene delivery to mammalian cells J Virol 1996; 70: 62-67.
25. Ho DY, McLaughlin JR, Sapolsky KM, Inducible gene expression from defective herpes simplex virus vectors using the tetracycline-responsive promoter system. Mol Brain Res 1996; 41: 200-209.
26. Hofmann A, Nolan GP, Blau HM. Rapid retroviral delivery of tetracycline-inducible genes in a single autoregulatory cassette. Proc Natl Acad Sci USA 1996; 93: 5185-5190.
27. O'Brien K, Otto K, Rao RN. Construction and characterization of a one-plasmid system for the controlled expression of genes in mammalian cells by tetracycline. Gene 1997; 184: 115-120.
28. Baron U, Freundlieb S, Gossen M, Bujard H. Co-regulation of two gene activities by tetracycline via a bidirectional promoter. Nucleic Acids Res 1995; 23: 3605-3606.
29. Howe JR et al. The responsiveness of a tetracycline-sensitive expression system differs in different cell lines. J Biol Chem 1995; 270: 14168-14174.
30. Shockett P, Difilippantonio M, Hellman N, Schatz DG. A modified tetracycline-regulated system provides autoregulatory, inducible gene expression in cultured cells and transgenic mice. Proc Natl Acad Sci USA 1995; 92: 6522-6526.
31. Ackland-Berglund CE, Leib DA. Efficacy of tetracycline-controlled gene expression is influenced by cell type. Biotechniques 1995; 18 196-200.
32. A-Mohammadi S, Alvarez-Vallina L, Ashworth LJ, Hawkins RE. Delay in resumption of the activity of tetracycline-regulatable promoter following removal of Tc analogues. Gene Therapy 1997; 4. 993-997.
33. Gill G, Ptashne M. Negative effect of the transcriptional activator GAL4. Nature 1988; 334: 721-724.
34. Berger SL et al. Selective inhibition of activated but not basal transcription by the acidic activation domain of VP16: evidence for transcriptional adaptors. Cell 1990; 61. 1199-1208.
35. Just U, Stocking C, Dexter TM, Ostertag W. Expression of the GM-CSF gene after retroviral transfer in hematopoietic stem cell lines induces synchronous granulocyte-macrophage differentiation. Cell 1991; 64: 1163-1170.
36. Wasylyk B, Wasylyk C, Chambon P. Short and long range activation by the SV40 enhancer. Nucleic Acids Res 1984; 12: 5589-5608.
37. Gossen M et al. Transcriptional activation by tetracyclines in mammalian cells. Science 1995; 268: 1766-1769.
38. Miller K, Rizzino A. The function of inducible promoter systems in F9 embryonal carcinoma cells. Exp Cell Res 1995; 218: 144-150.
39. Hwang JJ, Scuric Z, Anderson WF. Novel retroviral vector transferring a suicide gene and a selectable marker gene with enhanced gene expression by using a tetracycline-responsive expression system. J Virol 1996, 70: 8138-8141.
40. Mitchell PJ, Tjian R. Transcriptional regulation in mammalian cells by sequence-specific DNA binding proteins. Science 1989; 245: 371-378.
41. Emami KH, Navarre WW, Smale ST. Core promoter specificities of the Sp1 and VP16 transcriptional activation domains. Mol Cell Biol 1995; 15: 5906-5916.
42. Bowman BH et al. Discovery of a brain promoter from the human transferrin gene and its utilisation for development of transgenic mice that express human apolipoprotein E alleles. Proc Natl Acad Sci USA 1995; 92: 12115-12119.
43. Wood IC, Roopra A, Harrington C, Buckley NJ Structure of the m4 cholinergic muscarinic receptor gene and its promoter. J Biol Chem 1995; 270: 30933-30940.
44. Olson AL, Pessin JE. Transcriptional regulation of the human GLUT4 gene promoter in diabetic transgenic mice. J Biol Chem 1995; 270: 23491-23495.
45. Greenberg D et al. Liver-specific expression of the human factor VII gene. Proc Natl Acad Sci USA 1995; 92: 12347-12351.
46. Igarashi P, Whyte DA, Li K, Nagami GT. Cloning and kidney cell-specific activity of the promoter of the murine renal Na-K-Cl cotransporter gene. J Biol Chem 1996; 271: 9666-9674.
47. Sambrook J, Fritsch EF, Maniatis T. Molecular Cloning: A Laboratory Manual. Cold Spring Harbor Laboratory Press: Cold Spring Harbor, NY, 1989.
48. Pike BL, Raubitschek A, Nossal GJV. Human interleukin 2 can promote the growth and differentiation of single hapten-specific B cells in the presence of specific antigen. Proc Natl Acad Sci USA 1984; 81: 7917-7921.
49. Gheradi E, Pannell R, Milstein C. A single-step procedure for cloning and selection of antibody-secreting hybridomas. J Immunol Meth 1990; 126: 61-68.
50. Kozak M. Point mutations define a sequence flanking the AUG initiator codon that modulates translation by eukaryotic ribosomes. Cell 1986; 44: 283-292.
51. Markowitz D, Goff S, Bank A. Construction and use of a safe and efficient amphotropic packaging cell line Virology 1988; 167: 400-406.